Results 151 to 160 of about 76,948 (211)

Suzetrigine: a novel allosteric voltage-gated sodium 1.8 channel inhibitor, thereby stabilizing the closed state of the channel. [PDF]

Korean J Pain
Kim KH.
europepmc   +1 more source

Factors affecting voriconazole pharmacokinetic variability in critically ill patients: a systematic review. [PDF]

Crit Care
Coste A, Aubron C, Ansart S, Roberts J, Morio F, Grégoire M.   +5 more
europepmc   +1 more source

New Insights into Prostate Cancer Susceptibility in European Caucasians: A Systematic Review and Meta-Analysis of CYP3A4 Pharmacogene. [PDF]

Cancers (Basel)
Pagoni M, Cava C, Tsangaris GT, Siannis F, Drakoulis N.   +4 more
europepmc   +1 more source

Type 2 diabetes mellitus as a state of altered drug pharmacokinetic-pharmacodynamic parameters: an update on recent developments and clinical implications. [PDF]

Ther Adv Endocrinol Metab
Sibiya N, Onyekwuluje C, Kuretu A, Ayodele O, Ngcobo N, Ngubane P, Khathi A.   +6 more
europepmc   +1 more source

The Effect of Ecopipam on the Pharmacokinetics of Concomitant Medications. [PDF]

Clin Transl Sci
Schmith VD, Graden D, Lohmer LLR, Schleyer J, Wanaski SP.   +4 more
europepmc   +1 more source

Antioxidant Properties of Novel Lipophilic Fluoroquinolone Compounds Against Oxidative Stress Induced by Acetaminophen and Carbon Tetrachloride in Male Wistar Rats. [PDF]

Biomolecules
Alwahsh M, Shawaqfeh B, Alejel R, Hasan A, Yousef D, Saqallah FG, Al-Kouz S, Alassi A, Swaiss Y, Al-Hiari Y, Al-Qirim T.   +10 more
europepmc   +1 more source

Molecular dynamics simulations elucidate the role of the F-F' loop in substrate entry into CYP3A4. [PDF]

Commun Chem
Yan J, Hirao H.
europepmc   +1 more source

A new metabolic path in type 3 rickets. [PDF]

FEBS J
Senda T, Hirota Y.
europepmc   +1 more source

Allelic variation in CYP3A4 and PLB1 drives feed efficiency and immunometabolic resilience in beef cattle. [PDF]

BMC Genomics
Morenikeji OB, Idowu M, Taiwo G, Gratz LM, Olabosoye B, King RE, Andrews ND, Saccoh F, Grytsay A, Marshall MC, Ogunade IM.   +10 more
europepmc   +1 more source

Potential Drug Interactions in Psychiatric Patients Undergoing Pangenotypic Therapy for Hepatitis C Virus Infection. [PDF]

Pharmaceuticals (Basel)
Dybowska D, Pawłowska M, Kozielewicz D.
europepmc   +1 more source